Skeletal muscle expression of the adhesion-GPCR CD97: CD97 deletion induces an abnormal structure of the sarcoplasmatic reticulum but does not impair skeletal muscle function

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Zyryanova, Tatiana ^a,c   Schneider, Rick ^a   Adams, Volker ^a   Sittig, Doreen ^a   Kerner, Christiane ^a   Gebhardt, Claudia ^a   Ruffert, Henrik ^a   Glasmacher, Stefan ^a   Hepp, Pierre ^a   Punkt, Karla ^a   Neuhaus, Jochen ^a   Hamann, Jörg ^b   Aust, Gabriela ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; CALCIUM ION; CD97 ANTIGEN; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; CALCIUM CHANNEL L TYPE; CD97 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; RYANODINE;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL LABELING; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAST MUSCLE FIBER; FEMALE; FLOW CYTOMETRY; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MIDDLE AGED; MOUSE; MUSCLE CELL; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE MITOCHONDRION; MUSCLE STRENGTH; NONHUMAN; PRESCHOOL CHILD; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; RHABDOMYOSARCOMA; RUNNING; SARCOLEMMA; SARCOPLASMIC RETICULUM; SLOW MUSCLE FIBER; SOLEUS MUSCLE; TRANSVERSE TUBULAR SYSTEM; VASTUS MEDIALIS MUSCLE; YOUNG ADULT; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SKELETAL MUSCLE; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD; CALCIUM CHANNELS, L-TYPE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; RHABDOMYOSARCOMA; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOLEMMA; SARCOPLASMIC RETICULUM;

EID: 84903396984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100513     Document Type: Article

References (48)

1. Yona S, Lin HH, Siu WO, Gordon S, Stacey M (2008) Adhesion-GPCRs: emerging roles for novel receptors. Trends Biochem Sci 33: 491-500.
2. Langenhan T, Aust G, Hamann J (2013) Sticky signaling - Adhesion class G protein-coupled receptors take the stage. Sci Signal 6: re3. doi: 10.1126/scisignal.2003825.
3. Lin HH, Chang GW, Davies JQ, Stacey M, Harris J, et al. (2004) Autocatalytic cleavage of the EMR2 receptor occurs at a conserved G protein-coupled receptor proteolytic site motif. J Biol Chem 279: 31823-31832. (Pubitemid 39037855)
4. Arac D, Boucard AA, Bolliger MF, Nguyen J, Soltis SM, et al. (2012) A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. EMBO J 31: 1364-1378.
5. Eichler W, Aust G, Hamann D (1994) Characterization of the early activationdependent antigen on lymphocytes defined by the monoclonal antibody BLAc(F2). Scand J Immunol 39: 111-115. (Pubitemid 24232906)
6. Aust G, Eichler W, Laue S, Lehmann I, Heldin N-E, et al. (1997) CD97: A dedifferentiation marker in human thyroid carcinomas. Cancer Res 57: 1798-1806. (Pubitemid 27199676)
7. Jaspars LH, Vos W, Aust G, van Lier RA, Hamann J (2001) Tissue distribution of the human CD97 EGF-TM7 receptor. Tissue Antigens 57: 325-331. (Pubitemid 32511301)
8. Steinert M, Wobus M, Boltze C, Schütz A, Wahlbuhl M, et al. (2002) Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol 161: 1657-1667. (Pubitemid 35265525)
9. Veninga H, Becker S, Hoek RM, Wobus M, Wandel E, et al. (2008) Analysis of CD97 expression and manipulation: antibody treatment but not gene targeting curtails granulocyte migration. J Immunol 181: 6574-6583.
10. Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, et al. (1996) CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157: 5438-5447. (Pubitemid 126448963)
11. Hamann J, Vogel B, van Schijndel GM, van Lier RA (1996) The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184: 1185-1189. (Pubitemid 26313577)
12. Stacey M, Chang GW, Davies JQ, Kwakkenbos MJ, Sanderson RD, et al. (2003) The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulphate glycosaminoglycans. Blood 102: 2916-2924. (Pubitemid 37248865)
13. Kwakkenbos MJ, Pouwels W, Matmati M, Stacey M, Lin HH, et al. (2005) Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. J Leukoc Biol 77: 112-119. (Pubitemid 40310699)
14. Wang T, Ward Y, Tian L, Lake R, Guedez L, et al. (2004) CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counter receptors on endothelial cells. Blood 105: 2836-2844. (Pubitemid 40446277)
15. Wandel E, Saalbach A, Sittig D, Gebhardt C, Aust G (2012) Thy-1 (CD90) is an interaction partner for CD97 on activated endothelial cells. J Immunol 188: 1442-1450.
16. Becker S, Wandel E, Wobus M, Schneider R, Amasheh S, et al. (2010) Overexpression of CD97 in intestinal epithelial cells of transgenic mice attenuates colitis by strengthening adherens junctions. PLoS ONE 5: e8507.
17. Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, et al. (2006) Individual cell - based models of tumor - environment interactions. Multiple effects of CD97 on tumor invasion. Am J Pathol 169: 1802-1811. (Pubitemid 351182009)
18. Pickl WF, Majdic O, Mai I, Gadd S, Knapp W (1995) Overview of CD97. In: Schlossman SF, Boumsell L, Gilks W, Halan JM, Morimoto C et al., editors. Leucocyte Typing V. Oxford, New York, Tokyo: Oxford University Press. pp. 1151-1153.
19. Wobus M, Vogel B, Schmücking E, Hamann J, Aust G (2004) N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Int J Cancer 112: 815-822. (Pubitemid 39435266)
20. Karpus ON, Veninga H, Hoek RM, Flierman D, van Buul JD, et al. (2013) Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55. J Immunol 190: 3740-3748.
21. Aust G, Wandel E, Boltze C, Sittig D, Schütz A, et al. (2006) Diversity of CD97 in smooth muscle cells (SMCs). Cell Tissue Res 323: 1-9.
22. Rossi AE, Dirksen RT (2006) Sarcoplasmic reticulum: The dynamic calcium governor of muscle. Muscle Nerve 33: 715-731. (Pubitemid 43856788)
23. Bottinelli R, Reggiani C (2000) Human skeletal muscle fibres: molecular and functional diversity. Prog Biophys Mol Biol 73: 195-262.
24. Punkt K (2002) Fibre types in skeletal muscles. Adv Anat Embryol Cell Biol 162:III-XV: 1-109.
25. Punkt K, Fritzsche M, Stockmar C, Hepp P, Josten C, et al. (2006) Nitric oxide synthase in human skeletal muscles related to defined fibre types. Histochem Cell Biol 125: 567-573. (Pubitemid 43673519)
26. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, et al. (2007) Evidence based selection of housekeeping genes. PLoS ONE 2: e898.
27. Wetzel P, Gros G (1998) Inhibition and kinetic properties of membrane-bound carbonic anhydrases in rabbit skeletal muscles. Arch Biochem Biophys 356: 151-158. (Pubitemid 28387719)
28. Weibel ER (1969) Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 26:235-302.: 235-302.
29. Keire P, Shearer A, Shefer G, Yablonka-Reuveni Z (2013) Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Methods Mol Biol 946: 431-468.
30. Shaw MA, Ostap EM, Goldman YE (2003) Mechanism of inhibition of skeletal muscle actomyosin by N-benzyl-p-toluenesulfonamide. Biochemistry 42: 6128-6135. (Pubitemid 36605114)
31. Wehner M, Rueffert H, Koenig F, Neuhaus J, Olthoff D (2002) Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation. Clin Genet 62: 135-146. (Pubitemid 36372713)
32. Grange RW, Gainer TG, Marschner KM, Talmadge RJ, Stull JT (2002) Fast-twitch skeletal muscles of dystrophic mouse pups are resistant to injury from acute mechanical stress. Am J Physiol Cell Physiol 283: C1090-C1101.
33. Hamann J, Eichler W, Vogel B, Stortelers C, Hamann D, et al. (1997) CD97 workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEGKr, Goyert SM, Mason DY et al., editors. Leucocyte Typing VI. White Cell Differentiation Antigens. New York, London: Garland Publishing, Inc. pp. 527-529.
34. Kwakkenbos MJ, van Lier RA, Hamann J (2001) Characterization of EGF-TM7 family members by novel monoclonal antibodies. In: Mason D, editors. Leucocyte Typing VII. White Cell Differentiation Antigens. Oxford: Oxford University Press. pp. 381-383.
35. Calderon JC, Bolanos P, Torres SH, Rodriguez-Arroyo G, Caputo C (2009) Different fibre populations distinguished by their calcium transient characteristics in enzymatically dissociated murine flexor digitorum brevis and soleus muscles. J Muscle Res Cell Motil 30: 125-137.
36. Sjaland C, Lunde PK, Swift F, Munkvik M, Ericsson M, et al. (2011) Slowed relaxation and preserved maximal force in soleus muscles of mice with targeted disruption of the Serca2 gene in skeletal muscle. J Physiol 589: 6139-6155.
37. Yoshida M, Minamisawa S, Shimura M, Komazaki S, Kume H, et al. (2005) Impaired Ca2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice. J Biol Chem 280: 3500-3506. (Pubitemid 40223815)
38. Juretic N, Urzua U, Munroe DJ, Jaimovich E, Riveros N (2007) Differential gene expression in skeletal muscle cells after membrane depolarization. J Cell Physiol 210: 819-830. (Pubitemid 46185051)
39. Poelkens F, Lammers G, Pardoel EM, Tack CJ, Hopman MT (2013) Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome. Exp Physiol 98: 1485-1494.
40. Hochreiter-Hufford AE, Lee CS, Kinchen JM, Sokolowski JD, Arandjelovic S, et al. (2013) Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature 497: 263-267.
41. Cerletti M, Molloy MJ, Tomczak KK, Yoon S, Ramoni MF, et al. (2006) Melanoma cell adhesion molecule is a novel marker for human fetal myogenic cells and affects myoblast fusion. J Cell Sci 119: 3117-3127. (Pubitemid 44322126)
42. Wu MP, Doyle JR, Barry B, Beauvais A, Rozkalne A, et al. (2013) GPR56 promotes myoblast fusion through SRE- and NFAT-mediated signaling but is not essential for muscle development in vivo. FEBS J 280: 6097-6113.
43. Schmidt RA, Cone R, Haas JE, Gown AM (1988) Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol 131: 19-28.
44. Parham DM, Webber B, Holt H, Williams WK, Maurer H (1991) Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma study project. Cancer 67: 3072-3080.
45. Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, et al. (1999) Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Arthritis Rheum 42: 650-658. (Pubitemid 29171984)
46. Hsiao CC, Cheng KF, Chen HY, Chou YH, Stacey M, et al. (2009) Site-specific N-glycosylation regulates the GPS auto-proteolysis of CD97. FEBS Lett 583: 3285-3290.
47. Hamann J, van Zeventer C, Bijl A, Molenaar C, Tesselaar K, et al. (2000) Molecular cloning and characterization of mouse CD97. Int Immunol 12: 439-448. (Pubitemid 30199349)
48. Leemans JC, te Velde AA, Florquin S, Bennink RJ, de Bruin K, et al. (2004) The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol 172: 1125-1131. (Pubitemid 38120256)